Rhode Island H8318 prohibits testosterone prescriptions from being transmitted or reported in the prescription drug monitoring database and removes.
Rhode Island H8318 amends the Uniform Controlled Substances Act to prevent prescriptions for testosterone from being transmitted or reported within the state's prescription drug monitoring database. The bill also mandates the removal of all existing information concerning prior testosterone prescriptions from the database. This act aims to protect patient privacy by excluding testosterone prescriptions from the monitoring system. The changes will take effect immediately upon the bill's passage.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.